Skip to Main Content

Paper Details

Molecular heterogeneity and co-altered genes in MET-amplified ALK-positive lung cancer: Implications for MET targeted therapy.
Lung Cancer
0
2023
Author NameAffiliation
Jochen K LennerzHarvard Medical School, Center for Integrated Diagnostics, Massachusetts General Hospital
  • 1 - 1

Datasets

Release 1.2